Skip to main content
. 2025 Sep 1;23:972. doi: 10.1186/s12967-025-06991-5

Table 1.

Clinical parameters of the two groups enrolled in the study

Parameters Cases (n = 40)
CeD patients
Controls (n = 40)
Healthy volunteers
Statistical value P value
Min–max age 19–65 19–66
Mean age ± SD 44 ± 12.0 42.6 ± 11.9 t = 0.513 0.994
Sex F/M (%F) 29F/11 M (72.5%) 29F/11 M (72.5%) – –
BMI 20.16 ± 4.3 20.33 ± 3.93 t = − 0.185 0.691
Nationality (%) – –
 Han 6/40 (15%) 6/40 (15%)
 Kazakh 15/40 (37.5%) 15/40 (37.5%)
 Uygur 19/40 (47.5%) 19/40 (47.5%)
Disease comorbidities (%)
 Thyroid diseases 12/40 (30%) 4/40 (7.5%) χ2 = 5.000 0.025
 Osteoporosis 12/40 (30%) 4/40 (10%) χ2 = 5.000 0.025
 Anemic 14/40 (35%) 2/40 (5%) χ2 = 11.250 0.001
 Vitamin D deficiency 17/40 (42.5%) 7/40 (22.5%) χ2 = 5.952 0.015
 Anxiety and depression 2/40 (5%) 0/40 (0%) χ2 = 2.051 0.152
Mean tTG-IgA (% +)

2596.2

40/40 (+) (100%)

0/40 (−) (0%)

Duodenal biopsy

 (Marsh index) (%)

5/40 M3a (12.5%)

16/40 M3b (12.5%)

19/40 M3c (47.5%)

40/40 M0 (100%)

Clinical symptoms (%)

 (Classical/non-classical)

18/40 Cla (45%)

22/40 N-Cla (55%)

–

CeD celiac disease, BMI body mass index, F female, M male, tTG -IgA anti tissue-transglutaminase 2 IgA, Marsh Index M3a: Marsh 3A, M3b: Marsh 3B, M3c: Marsh 3C